Amyris closes strategic transaction with givaudan

Leveraging amyris' industry-leading biotechnology platform in beauty for the development and supply of clean sustainable ingredients emeryville, calif. , april 5, 2023 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-market™ technology platform and clean beauty consumer brands, announced that it has completed the previously announced strategic transaction with givaudan sa for the worldwide exclusive licensing of certain cosmetic ingredients, including neossance® squalane, the highest performant emollient, neossance® hemisqualane, the plant-based silicone alternative, and cleanscreen™, the sustainable sun protector.
AMRS Ratings Summary
AMRS Quant Ranking